The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

The 76-year-old Oscar winner got serious about her health following her diagnosis for type 2 diabetes in 2017, but there was ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an additional 38% considered overweight. This epidemic not only impacts individual ...

With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...

CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring ...

Desperate to find her version of healthy, the plus-size influencer lost weight—a lot of it. But nothing is as perfect as it ...

New weight loss drugs like Ozempic and Wegovy help suppress appetite, leading to significant weight loss, but they come with ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Semaglutide, branded as Rybelsus, Wegovy or Mounjaro, most popularly identified by Ozempic (as branded by Danish pharma giant ...

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong ...

Only time will tell if the recently enacted health-care reform laws can rein in the uncontrollable costs that have created ...

Unlike conventional diabetes and weight-loss drugs, Mounjaro works by enhancing ... that the market would double after the launch of Rybelsus (oral semaglutide), but it actually grew 22 times ...